Search

everythinglearnresearchcommunity

for

Search:↓

Glycyrrhizinic acid spray showed limited effectiveness in treating anogenital warts in HIV patients with low CD4 levels.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

The cream with xyloglucan, pea protein, and cactus extract works as well as the standard treatment for psoriasis and is well-tolerated.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

Long-term treatment with palbociclib plus letrozole maintains quality of life in certain breast cancer patients.

Mesenchymal stem cells from laser-assisted liposuction are as effective and safe as those from conventional methods for cell therapy.

Upadacitinib may effectively treat resistant lichen planopilaris.

Clofazimine effectively treated ashy dermatosis in a patient.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Gestrinone pellets may help reduce pelvic pain in endometriosis safely.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

Cantú syndrome may be linked to pituitary adenomas.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

Oral tofacitinib successfully treated total body hair loss in one patient.

A new 3D breast tumor model helps test drug effects more accurately than traditional methods.

Aumolertinib is effective and well-tolerated for treating advanced lung cancer with EGFR mutations.

Aumolertinib effectively controls lung cancer and improves quality of life.

Hedgehog pathway inhibitors could be effective in treating melanoma.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Cinacalcet may help treat hereditary vitamin D resistant rickets safely.

Tofacitinib effectively and safely promotes hair regrowth in alopecia patients.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.